Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Lexicon Pharmaceuticals (LXRX) Shares Repurchased (2023 - 2024)

Lexicon Pharmaceuticals (LXRX) has disclosed Shares Repurchased for 4 consecutive years, with $1.7 million as the latest value for Q1 2024.

  • Quarterly Shares Repurchased rose 109.95% to $1.7 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2024, up 109.95% year-over-year, with the annual reading at $1.7 million for FY2024, 109.95% up from the prior year.
  • Shares Repurchased for Q1 2024 was $1.7 million at Lexicon Pharmaceuticals, up from $824000.0 in the prior quarter.
  • The five-year high for Shares Repurchased was $1.7 million in Q1 2024, with the low at $824000.0 in Q1 2023.